CLINICAL_TRIALS
trial_result
· 2017-04-20
Clinical Trial Update: Rituximab in Treating Patients With Hodgkin's Lymphoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating rituximab in Hodgkin lymphoma has completed; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ranjana Advani | Conditions: Lymphoma, Hodgkin Lymphoma (Category) | Phase 2 | Status: COMPLETED | Results posted: 2017-04-20